Zafirlukast is a broad-spectrum thiol isomerase inhibitor that inhibits thrombosis without altering bleeding times.

Br J Pharmacol · 2021 · PMC9328650 · PMID 33080041

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Incubation with lower concentrations of zafirlukast (0.1–5 μM) showed a trend towards inhibition but did not reach significance.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.